1) Michel T, Hoffman BB. Treatment of Myocardial Ischemia and Hypertension. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 752-53.

2) Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 197.

3) Tadalafil. Basingstoke, Hampshire: Eli Lilly and Company Limited; 2002 [revised 23 Mar. 2017]. [Accessed 04 Apr. 2019] Link

4) Tadalafil. Indianapolis, Indiana: Eli Lilly and Company; 2007. [Accessed 04 Apr. 2019] Link

5) Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2008 Dec;4(6):1315-30. [Accessed 12 Jul. 2024] Link

6) Frajese GV, Pozzi F, Frajese G. Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence. Clin Interv Aging. 2006;1(4):439-49. [Accessed 12 Jul. 2024] Link

7) Motawi AT, GamalEl Din SF, Meatmed EM, et al. Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study. Int Urol Nephrol. 2024 Mar 4. [Accessed 12 Jul. 2024] Link

8) Ma J, Liu Z, Wu J, et al. Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials. Transl Androl Urol. 2020 Jun;9(3):1405-1414. [Accessed 12 Jul. 2024] Link

9) Shamohammadi I, Kazemeyni S, Sadighi M, et al. Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial. Asian J Urol. 2022 Aug 13;11(1):128-33. [Accessed 12 Jul. 2024] Link